Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun J Yang

Showing results (71-80 of 232) with videos related to

Pageof 24
Sort By:
Journal of Medicinal Chemistry|July 8, 2024
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic LeukemiaJamie A Jarusiewicz, Satoshi Yoshimura, Marisa Actis, et al.
Hepatology (Baltimore, Md.)|February 18, 2022
A developmentally prometastatic niche to hepatoblastoma in neonatal liver mediated by the Cxcl1/Cxcr2 axisLi Fan, Qingfei Pan, Wentao Yang, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACsLisa J Alcock, Yunchao Chang, Jamie A Jarusiewicz, et al.
Blood Advances|November 19, 2024
Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical modelsSankaranarayanan Kannan, Yizhen Li, Natalia Baran, et al.
Haematologica|May 28, 2026
Presentation and management of pediatric T-cell acute lymphoblastic leukemia with mediastinal mass and hyperleukocytosisBradley Muller, Yin Su, Alaina Rule, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemiaJun J Yang, Wendy Landier, Wenjian Yang, et al.
Leukemia|April 19, 2023
Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemiaSatoshi Yoshimura, John C Panetta, Jianzhong Hu, et al.
ACS Medicinal Chemistry Letters|February 16, 2023
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC DesignJamie A Jarusiewicz, Satoshi Yoshimura, Anand Mayasundari, et al.
JCI Insight|May 10, 2022
MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymusKirsten Canté-Barrett, Mariska T Meijer, Valentina Cordo', et al.
Clinical Pharmacology and Therapeutics|October 30, 2020
Effects of NT5C2 Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic LeukemiaChuang Jiang, Wenjian Yang, Takaya Moriyama, et al.
Pageof 24

Showing results (71-80 of 232) with videos related to

Sort By:
Pageof 24
Journal of Medicinal Chemistry|July 8, 2024
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic LeukemiaJamie A Jarusiewicz, Satoshi Yoshimura, Marisa Actis, et al.
Hepatology (Baltimore, Md.)|February 18, 2022
A developmentally prometastatic niche to hepatoblastoma in neonatal liver mediated by the Cxcl1/Cxcr2 axisLi Fan, Qingfei Pan, Wentao Yang, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACsLisa J Alcock, Yunchao Chang, Jamie A Jarusiewicz, et al.
Blood Advances|November 19, 2024
Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical modelsSankaranarayanan Kannan, Yizhen Li, Natalia Baran, et al.
Haematologica|May 28, 2026
Presentation and management of pediatric T-cell acute lymphoblastic leukemia with mediastinal mass and hyperleukocytosisBradley Muller, Yin Su, Alaina Rule, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemiaJun J Yang, Wendy Landier, Wenjian Yang, et al.
Leukemia|April 19, 2023
Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemiaSatoshi Yoshimura, John C Panetta, Jianzhong Hu, et al.
ACS Medicinal Chemistry Letters|February 16, 2023
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC DesignJamie A Jarusiewicz, Satoshi Yoshimura, Anand Mayasundari, et al.
JCI Insight|May 10, 2022
MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymusKirsten Canté-Barrett, Mariska T Meijer, Valentina Cordo', et al.
Clinical Pharmacology and Therapeutics|October 30, 2020
Effects of NT5C2 Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic LeukemiaChuang Jiang, Wenjian Yang, Takaya Moriyama, et al.
Pageof 24